NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam 2026/2027 | Page 1 | Passing Score: 80%
CHAMBERLAIN COLLEGE
inal Exam| Questions and 100% Correct Answers | Rated A
xam| Questions and 100% Correct Answers | Rated A Quiz bank | LATEST, 2026/2027 | Chamberla
50 80% See Provider
QUESTIONS PASSING SCORE RECERTIFICATION
INCLUDES DETAILED ANSWERS WITH RATIONALE FOR EVERY QUESTION
TABLE OF CONTENTS
Section 1 Pharmacokinetics and Pharmacodynamics Q1-Q10
Section 2 Autonomic and Cardiovascular Pharmacology Q11-Q20
Section 3 CNS and Psychiatric Pharmacology Q21-Q30
Section 4 Anti-infectives and Chemotherapy Q31-Q40
Section 5 Endocrine and Miscellaneous Drug Classes Q41-Q50
Instructions: Select the single best answer for each question. This exam includes detailed answers with full rationale after every
question. Passing score: 80% (40 questions correct).
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 1 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q1 Question 1 of 50
A 68-year-old male with chronic kidney disease (eGFR 28 mL/min) is prescribed a medication
that is 90% renally excreted. The prescriber needs to adjust the dosing regimen to avoid
toxicity. What is the most appropriate initial pharmacokinetic adjustment for this patient?
A. Increase the dosing interval while keeping the same dose
B. Decrease the dosing interval while keeping the same dose
C. Increase the dose while keeping the same dosing interval
D. Add a second medication to enhance renal clearance
Correct Answer: A
Detailed
For drugsAnswer:
that are primarily renally excreted, the most appropriate initial adjustment in renal impairment is to
increase the dosing interval while maintaining the same dose, which prevents accumulation and toxicity.
Decreasing the dosing interval would increase accumulation and risk toxicity, and increasing the dose would
worsen the problem.
Q2 Question 2 of 50
A 45-year-old female is taking warfarin for atrial fibrillation and is newly prescribed fluconazole
for a vaginal candidiasis infection. Two weeks later, her INR is markedly elevated at 6.2. What
pharmacokinetic interaction best explains this finding?
A. Fluconazole induces CYP2C9, increasing warfarin activation
B. Fluconazole inhibits CYP2C9, decreasing warfarin metabolism
C. Fluconazole increases warfarin protein binding in plasma
D. Fluconazole enhances renal excretion of warfarin metabolites
Correct Answer: B
Detailed Answer:
Fluconazole is a potent inhibitor of CYP2C9, the primary enzyme responsible for metabolizing the more
potent S-enantiomer of warfarin. Inhibition of this enzyme decreases warfarin metabolism, leading to
elevated INR and bleeding risk. Induction of CYP2C9 would lower INR, not raise it.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 2 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q3 Question 3 of 50
A 52-year-old male with epilepsy has been taking phenytoin 300 mg daily for five years with
stable seizure control. Recent blood work reveals an albumin level of 2.1 g/dL due to
nephrotic syndrome. His total phenytoin level is reported as 8 mcg/mL. What is the most
accurate interpretation of this drug level?
A. The free phenytoin level is likely subtherapeutic and the dose should be increased
B. The free phenytoin level is likely therapeutic or elevated despite the low total level
C. The total phenytoin level accurately reflects therapeutic range and no change is needed
D. The phenytoin level should be rechecked after increasing the albumin level
Correct Answer: B
Detailed
PhenytoinAnswer:
is highly protein-bound to albumin, and in hypoalbuminemia, the total phenytoin level
underestimates the free (active) drug concentration. A corrected total level or a direct free phenytoin level
would more accurately reflect that the patient is likely at a therapeutic or elevated free drug concentration.
Simply increasing the dose based on total level would risk toxicity.
Q4 Question 4 of 50
A 34-year-old female presents to the clinic requesting a prescription for an oral contraceptive.
She has a history of migraines with aura and smokes one pack of cigarettes per day. What
pharmacodynamic principle most directly contraindicates combined oral contraceptive use in
this patient?
A. Estrogen-mediated increase in hepatic cytochrome P450 enzyme activity
B. Estrogen-mediated enhancement of platelet aggregation and coagulation cascade
C. Progesterone-mediated reduction in seizure threshold
D. Estrogen-mediated decrease in renal prostaglandin synthesis
Correct Answer: B
Detailed
CombinedAnswer:
oral contraceptives contain estrogen, which increases the synthesis of coagulation factors and
reduces antithrombin III, thereby promoting a hypercoagulable state. In a patient with migraines with aura
who smokes, the risk of ischemic stroke is substantially increased due to this prothrombotic
pharmacodynamic effect. The other options do not describe the primary mechanism of concern.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 3 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q5 Question 5 of 50
A 60-year-old male receives an intravenous bolus of a new antibiotic. Plasma drug
concentrations are measured at multiple time points, and a semilogarithmic plot of
concentration versus time reveals a biexponential decline. What pharmacokinetic concept
does this biphasic curve represent?
A. Zero-order elimination with saturable metabolism
B. Two-compartment model with distribution and elimination phases
C. One-compartment model with first-order elimination
D. Nonlinear pharmacokinetics due to enzyme saturation
Correct Answer: B
Detailed Answer:
A biexponential decline on a semilogarithmic concentration-time plot indicates a two-compartment
pharmacokinetic model, where the initial rapid decline represents distribution from the central to the
peripheral compartment and the slower terminal decline represents elimination. A one-compartment model
would show a monoexponential (single straight line) decline.
Q6 Question 6 of 50
A 72-year-old female with heart failure and NYHA Class III symptoms requires initiation of an
ACE inhibitor. She weighs 50 kg and has a serum creatinine of 1.8 mg/dL. What
pharmacokinetic principle best explains why a lower starting dose is recommended for this
patient?
A. ACE inhibitors undergo extensive first-pass metabolism that is impaired in heart failure
B. Reduced cardiac output decreases hepatic and renal perfusion, slowing drug elimination
C. ACE inhibitors are highly protein-bound and heart failure increases free drug concentration
D. Heart failure induces CYP3A4, accelerating ACE inhibitor metabolism
Correct Answer: B
Detailed Answer:
In heart failure, reduced cardiac output leads to decreased perfusion of the liver and kidneys, which are the
primary organs responsible for ACE inhibitor elimination. This results in a prolonged half-life and increased
risk of drug accumulation and adverse effects such as hypotension and hyperkalemia. Starting at a lower
dose mitigates this risk.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 4 of 32
CHAMBERLAIN COLLEGE
inal Exam| Questions and 100% Correct Answers | Rated A
xam| Questions and 100% Correct Answers | Rated A Quiz bank | LATEST, 2026/2027 | Chamberla
50 80% See Provider
QUESTIONS PASSING SCORE RECERTIFICATION
INCLUDES DETAILED ANSWERS WITH RATIONALE FOR EVERY QUESTION
TABLE OF CONTENTS
Section 1 Pharmacokinetics and Pharmacodynamics Q1-Q10
Section 2 Autonomic and Cardiovascular Pharmacology Q11-Q20
Section 3 CNS and Psychiatric Pharmacology Q21-Q30
Section 4 Anti-infectives and Chemotherapy Q31-Q40
Section 5 Endocrine and Miscellaneous Drug Classes Q41-Q50
Instructions: Select the single best answer for each question. This exam includes detailed answers with full rationale after every
question. Passing score: 80% (40 questions correct).
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 1 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q1 Question 1 of 50
A 68-year-old male with chronic kidney disease (eGFR 28 mL/min) is prescribed a medication
that is 90% renally excreted. The prescriber needs to adjust the dosing regimen to avoid
toxicity. What is the most appropriate initial pharmacokinetic adjustment for this patient?
A. Increase the dosing interval while keeping the same dose
B. Decrease the dosing interval while keeping the same dose
C. Increase the dose while keeping the same dosing interval
D. Add a second medication to enhance renal clearance
Correct Answer: A
Detailed
For drugsAnswer:
that are primarily renally excreted, the most appropriate initial adjustment in renal impairment is to
increase the dosing interval while maintaining the same dose, which prevents accumulation and toxicity.
Decreasing the dosing interval would increase accumulation and risk toxicity, and increasing the dose would
worsen the problem.
Q2 Question 2 of 50
A 45-year-old female is taking warfarin for atrial fibrillation and is newly prescribed fluconazole
for a vaginal candidiasis infection. Two weeks later, her INR is markedly elevated at 6.2. What
pharmacokinetic interaction best explains this finding?
A. Fluconazole induces CYP2C9, increasing warfarin activation
B. Fluconazole inhibits CYP2C9, decreasing warfarin metabolism
C. Fluconazole increases warfarin protein binding in plasma
D. Fluconazole enhances renal excretion of warfarin metabolites
Correct Answer: B
Detailed Answer:
Fluconazole is a potent inhibitor of CYP2C9, the primary enzyme responsible for metabolizing the more
potent S-enantiomer of warfarin. Inhibition of this enzyme decreases warfarin metabolism, leading to
elevated INR and bleeding risk. Induction of CYP2C9 would lower INR, not raise it.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 2 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q3 Question 3 of 50
A 52-year-old male with epilepsy has been taking phenytoin 300 mg daily for five years with
stable seizure control. Recent blood work reveals an albumin level of 2.1 g/dL due to
nephrotic syndrome. His total phenytoin level is reported as 8 mcg/mL. What is the most
accurate interpretation of this drug level?
A. The free phenytoin level is likely subtherapeutic and the dose should be increased
B. The free phenytoin level is likely therapeutic or elevated despite the low total level
C. The total phenytoin level accurately reflects therapeutic range and no change is needed
D. The phenytoin level should be rechecked after increasing the albumin level
Correct Answer: B
Detailed
PhenytoinAnswer:
is highly protein-bound to albumin, and in hypoalbuminemia, the total phenytoin level
underestimates the free (active) drug concentration. A corrected total level or a direct free phenytoin level
would more accurately reflect that the patient is likely at a therapeutic or elevated free drug concentration.
Simply increasing the dose based on total level would risk toxicity.
Q4 Question 4 of 50
A 34-year-old female presents to the clinic requesting a prescription for an oral contraceptive.
She has a history of migraines with aura and smokes one pack of cigarettes per day. What
pharmacodynamic principle most directly contraindicates combined oral contraceptive use in
this patient?
A. Estrogen-mediated increase in hepatic cytochrome P450 enzyme activity
B. Estrogen-mediated enhancement of platelet aggregation and coagulation cascade
C. Progesterone-mediated reduction in seizure threshold
D. Estrogen-mediated decrease in renal prostaglandin synthesis
Correct Answer: B
Detailed
CombinedAnswer:
oral contraceptives contain estrogen, which increases the synthesis of coagulation factors and
reduces antithrombin III, thereby promoting a hypercoagulable state. In a patient with migraines with aura
who smokes, the risk of ischemic stroke is substantially increased due to this prothrombotic
pharmacodynamic effect. The other options do not describe the primary mechanism of concern.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 3 of 32
,Pharmacokinetics and Pharmacodynamics | Q1-Q10 | NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Ex
Q5 Question 5 of 50
A 60-year-old male receives an intravenous bolus of a new antibiotic. Plasma drug
concentrations are measured at multiple time points, and a semilogarithmic plot of
concentration versus time reveals a biexponential decline. What pharmacokinetic concept
does this biphasic curve represent?
A. Zero-order elimination with saturable metabolism
B. Two-compartment model with distribution and elimination phases
C. One-compartment model with first-order elimination
D. Nonlinear pharmacokinetics due to enzyme saturation
Correct Answer: B
Detailed Answer:
A biexponential decline on a semilogarithmic concentration-time plot indicates a two-compartment
pharmacokinetic model, where the initial rapid decline represents distribution from the central to the
peripheral compartment and the slower terminal decline represents elimination. A one-compartment model
would show a monoexponential (single straight line) decline.
Q6 Question 6 of 50
A 72-year-old female with heart failure and NYHA Class III symptoms requires initiation of an
ACE inhibitor. She weighs 50 kg and has a serum creatinine of 1.8 mg/dL. What
pharmacokinetic principle best explains why a lower starting dose is recommended for this
patient?
A. ACE inhibitors undergo extensive first-pass metabolism that is impaired in heart failure
B. Reduced cardiac output decreases hepatic and renal perfusion, slowing drug elimination
C. ACE inhibitors are highly protein-bound and heart failure increases free drug concentration
D. Heart failure induces CYP3A4, accelerating ACE inhibitor metabolism
Correct Answer: B
Detailed Answer:
In heart failure, reduced cardiac output leads to decreased perfusion of the liver and kidneys, which are the
primary organs responsible for ACE inhibitor elimination. This results in a prolonged half-life and increased
risk of drug accumulation and adverse effects such as hypotension and hyperkalemia. Starting at a lower
dose mitigates this risk.
NR565 / NR565 Advanced Pharmacology Fundamentals Midterm / Final Exam - 2026/2027 | Official Exam with Detailed Answers | Passing Score: 80% | Page 4 of 32
